FDA 510(k)
FDA class 2
Substantially Equivalent
🇰🇷 South Korea
UROTEST GPH
K Number: K912244
·
Decision Nov 22, 1991
Classifications
1
FEI Numbers
2
Registration Numbers
2
Same Product Code
2
Applicant Total
1
Review Days
185
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- UROTEST GPH
- K Number
- K912244
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3560
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- In Wha Pharmaceutical Co., Ltd.
- Date Received
- May 21, 1991
- Decision Date
- November 22, 1991
- Product Code
- JII
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- CH
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| JII | Atomic Absorption, Lithium | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (JII), ordered by most recent decision date.
DIAZYME LIQUID STABLE ENZYMATIC LITHIUM ASSAY, MODEL DZ116B
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DIAZYME LITHIUM ENZYMATIC ASSAY KIT
FDA 510(k)
FDA Class 2
·Clinical Toxicology